Stay updated with breaking news from Expected Milestones. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”)Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones...
CNS Pharmaceuticals' (NASDAQ:CNSP) Ongoing Potentially Pivotal Study ...
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today reported its financial results for the quarter ended June 30, 2023, provided a corporate update and reiterates upcoming milestones.
Reported data from cohort 1 (n=3, 1E15 vg dose) of cystic fibrosis modulator treatment ineligible/intolerant participants with 9-12 months follow-up ...
FinancialContent fully hosted finance channel